RFK Jr. praises AI as a counter to medical expertise

By Splitfeed EditorialLast updated Sep 30, 2026, 20:20 UTC

On September 30, 2026, Robert F. Kennedy Jr. made public statements endorsing artificial intelligence as a tool for challenging conventional medical authority. Kennedy used the phrase "medical tyranny" to describe established medical facts and expertise, framing AI as a remedy against that authority. Both Politico and Ars Technica reported on the remarks the same day, with Politico describing Kennedy as putting a positive spin on AI and Ars Technica foregrounding the irony that AI systems are themselves imperfect and prone to hallucination.

The remarks matter because they arrive at a moment when trust in public health institutions is already fractured and AI is rapidly becoming a common source of health information for ordinary people. Kennedy has a long record of disputing mainstream medical consensus, and his embrace of AI is not a straightforward endorsement of the technology on its own terms. Instead, he is recruiting it into a broader argument about institutional authority. That framing raises a genuine dispute: whether AI, which draws on the same scientific literature and expert consensus Kennedy criticizes, can coherently serve as a counter to that consensus, or whether his characterization simply misrepresents how these systems work.

None of the three camps had published reactions at the time of reporting, so what follows reflects what each would typically argue about a story like this. The Pro-AI camp would likely resist Kennedy's framing, arguing that AI is a tool for expanding access to information rather than a weapon against expertise, and might worry that association with his views damages the case for AI in healthcare. The Anti-AI camp would probably seize on Kennedy's endorsement as evidence that AI poses real risks when used to circumvent medical guidance, pointing to hallucination rates as a concrete danger. The Middle Ground camp would likely call for better AI literacy and clearer labeling of AI health outputs, arguing that the problem is not AI itself but the absence of guardrails that distinguish reliable synthesis from misinformation.

The argument is unlikely to resolve around a single event, but watching whether Kennedy or his allies build policy proposals around AI as a tool for health decision-making, and how major AI health platforms respond to that framing, would clarify whether this remains a rhetorical moment or becomes something with concrete institutional consequences.